loading page

Age of people with Type 2 diabetes and the risk of dying following SARS-CoV-2 infection
  • +5
  • Zixing Tian,
  • Adrian Heald,
  • Mike Stedman,
  • Helene Fachim,
  • Mark Livingston,
  • Martin Gibson,
  • Yonghong Peng,
  • Bill Ollier
Zixing Tian
The University of Manchester
Author Profile
Adrian Heald
Salford Royal Hospitals NHS Trust
Author Profile
Mike Stedman
Res Consortium
Author Profile
Helene Fachim
Salford Royal Hospitals NHS Trust
Author Profile
Mark Livingston
Walsall Healthcare NHS Trust
Author Profile
Martin Gibson
Salford Royal Hospital
Author Profile
Yonghong Peng
Manchester Metropolitan University
Author Profile
Bill Ollier
University of Manchester
Author Profile

Abstract

Our analysis as described in this research letter highlights the fact that age outweighs many other factors in people with T2DM in relation to mortality from SARS-CoV-2 virus, once infected. This fact should be taken into account in relation to the vaccination programme against coronavirus-19 in people with T2DM in the UK and elsewhere.

Peer review status:ACCEPTED

31 Dec 2020Submitted to International Journal of Clinical Practice
02 Jan 2021Submission Checks Completed
02 Jan 2021Assigned to Editor
02 Jan 2021Reviewer(s) Assigned
06 Jan 2021Review(s) Completed, Editorial Evaluation Pending
10 Jan 20211st Revision Received
11 Jan 2021Submission Checks Completed
11 Jan 2021Assigned to Editor
11 Jan 2021Reviewer(s) Assigned
12 Jan 2021Review(s) Completed, Editorial Evaluation Pending
18 Jan 20212nd Revision Received
19 Jan 2021Submission Checks Completed
19 Jan 2021Assigned to Editor
20 Jan 2021Review(s) Completed, Editorial Evaluation Pending
23 Jan 2021Editorial Decision: Accept